Defining the minimal interacting regions of the tight junction protein MAGI-1 and HPV16 E6 oncoprotein for solution structure studies

Protein Expression and Purification

Volumn 60, Issue 1, 2008, Pages 64-73

  Charbonnier, Sebastian ^a   Stier, Gunter ^c   Orfanoudakis, Georges ^a   Kieffer, Bruno ^b   Atkinson, R Andrew ^b   Travé, Gilles ^a  

^a CNRS   (France)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

HPV oncoprotein E6; MAGI 1; PDZ domains; Sample quality optimization; Solution study

Indexed keywords

E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 20; MAGI1 PROTEIN, HUMAN; NERVE CELL ADHESION MOLECULE; ONCOPROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; CELL ADHESION MOLECULES, NEURONAL; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 43449137840     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.03.022     Document Type: Article

References (46)

1. de Villiers E.M. Human pathogenic papillomavirus types: an update. Curr. Top. Microbiol. Immunol. 186 (1994) 1-12
2. Dell G., and Gaston K. Human papillomaviruses and their role in cervical cancer. Cell Mol. Life Sci. 58 (2001) 1923-1942
3. Bosch F.X., and de Sanjose S. Human papillomavirus in cervical cancer. Curr. Oncol. Rep 4 (2002) 175-183
4. zur Hausen H., and de Villiers E.M. Human papillomaviruses. Annu. Rev. Microbiol. 48 (1994) 427-447
5. Clifford G.M., Smith J.S., Aguado T., and Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br. J. Cancer 89 (2003) 101-105
6. Pecorelli S., Favalli G., Zigliani L., and Odicino F. Cancer in women. Int. J. Gynaecol. Obstet. 82 (2003) 369-379
7. Schwarz E., Freese U.K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., and zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314 (1985) 111-114
8. Scheurer M.E., Tortolero-Luna G., and Adler-Storthz K. Human papillomavirus infection: biology, epidemiology, and prevention. Int. J. Gynecol. Cancer 15 (2005) 727-746
9. Song S., Pitot H.C., and Lambert P.F. The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals. J. Virol. 73 (1999) 5887-5893
10. Kiyono T. Roles of HPV genes in carcinogenesis. Uirusu 48 (1998) 125-135
11. Kiyono T., Hiraiwa A., Fujita M., Hayashi Y., Akiyama T., and Ishibashi M. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. USA 94 (1997) 11612-11616
12. Nguyen M.L., Nguyen M.M., Lee D., Griep A.E., and Lambert P.F. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J. Virol. 77 (2003) 6957-6964
13. Simonson S.J., Difilippantonio M.J., and Lambert P.F. Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential. Cancer Res. 65 (2005) 8266-8273
14. Thomas M., Laura R., Hepner K., Guccione E., Sawyers C., Lasky L., and Banks L. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 21 (2002) 5088-5096
15. Pim D., Thomas M., Javier R., Gardiol D., and Banks L. HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase. Oncogene 19 (2000) 719-725
16. Gardiol D., Kuhne C., Glaunsinger B., Lee S.S., Javier R., and Banks L. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18 (1999) 5487-5496
17. Lee S.S., Weiss R.S., and Javier R.T. Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. USA 94 (1997) 6670-6675
18. Nakagawa S., and Huibregtse J.M. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol. Cell. Biol. 20 (2000) 8244-8253
19. Glaunsinger B.A., Lee S.S., Thomas M., Banks L., and Javier R. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene 19 (2000) 5270-5280
20. Lee S., Maler L., and Dunn R.J. Differential expression of the PSD-95 gene family in electrosensory neurons. J. Comp. Neurol. 426 (2000) 429-440
21. Jing M., Bohl J., Brimer N., Kinter M., and Vande Pol S.B. Degradation of tyrosine phosphatase PTPN3 (PTPH1) by association with oncogenic human papillomavirus E6 proteins. J. Virol. 81 (2007) 2231-2239
22. Hampson L., Li C., Oliver A.W., Kitchener H.C., and Hampson I.N. The PDZ protein Tip-1 is a gain of function target of the HPV16 E6 oncoprotein. Int. J. Oncol. 25 (2004) 1249-1256
23. Favre-Bonvin A., Reynaud C., Kretz-Remy C., and Jalinot P. Human papillomavirus type 18 E6 protein binds the cellular PDZ protein TIP-2/GIPC, which is involved in transforming growth factor beta signaling and triggers its degradation by the proteasome. J. Virol. 79 (2005) 4229-4237
24. Jeong K.W., Kim H.Z., Kim S., Kim Y.S., and Choe J. Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation. Oncogene 26 (2007) 487-499
25. Ide N., Hata Y., Deguchi M., Hirao K., Yao I., and Takai Y. Interaction of S-SCAM with neural plakophilin-related Armadillo-repeat protein/delta-catenin. Biochem. Biophys. Res. Commun. 256 (1999) 456-461
26. Dobrosotskaya I., Guy R.K., and James G.L. MAGI-1, a membrane-associated guanylate kinase with a unique arrangement of protein-protein interaction domains. J. Biol. Chem. 272 (1997) 31589-31597
27. Kotelevets L., van Hengel J., Bruyneel E., Mareel M., van Roy F., and Chastre E. Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness. FASEB J. 19 (2005) 115-117
28. Doyle D.A., Lee A., Lewis J., Kim E., Sheng M., and MacKinnon R. Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ. Cell 85 (1996) 1067-1076
29. Thomas M., Glaunsinger B., Pim D., Javier R., and Banks L. HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation. Oncogene 20 (2001) 5431-5439
30. 15N resonance assignment, secondary structure and dynamic behaviour of the C-terminal domain of human papillomavirus oncoprotein E6. J. Biomol. NMR 31 (2005) 129-141
31. Nomine Y., Masson M., Charbonnier S., Zanier K., Ristriani T., Deryckere F., Sibler A.P., Desplancq D., Atkinson R.A., Weiss E., Orfanoudakis G., Kieffer B., and Trave G. Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis. Mol. Cell 21 (2006) 665-678
32. Zhang Y., Dasgupta J., Ma R.Z., Banks L., Thomas M., and Chen X.S. Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein. J. Virol. 81 (2007) 3618-3626
33. Liu Y., Henry G.D., Hegde R.S., and Baleja J.D. Solution structure of the hDlg/SAP97 PDZ2 domain and its mechanism of interaction with HPV-18 papillomavirus E6 protein. Biochemistry 46 (2007) 10864-10874
34. Nomine Y., Charbonnier S., Ristriani T., Stier G., Masson M., Cavusoglu N., Van Dorsselaer A., Weiss E., Kieffer B., and Trave G. Domain substructure of HPV E6 oncoprotein: biophysical characterization of the E6 C-terminal DNA-binding domain. Biochemistry 42 (2003) 4909-4917
35. Nomine Y., Ristriani T., Laurent C., Lefevre J.F., Weiss E., and Trave G. Formation of soluble inclusion bodies by hpv e6 oncoprotein fused to maltose-binding protein. Protein Expr. Purif. 23 (2001) 22-32
36. Nomine Y., Ristriani T., Laurent C., Lefevre J.F., Weiss E., and Trave G. A strategy for optimizing the monodispersity of fusion proteins: application to purification of recombinant HPV E6 oncoprotein. Protein Eng. 14 (2001) 297-305
37. Charbonnier S., Zanier K., Masson M., and Trave G. Capturing protein-protein complexes at equilibrium: the holdup comparative chromatographic retention assay. Protein Expr. Purif. 50 (2006) 89-101
38. Piotto M., Saudek V., and Sklenar V. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 2 (1992) 661-665
39. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
40. Eccles C., Guntert P., Billeter M., and Wuthrich K. Efficient analysis of protein 2D NMR spectra using the software package EASY. J. Biomol. NMR 1 (1991) 111-130
41. 1H resonance assignment of the PDZ1 domain of MAGI-1 using QUASI. J. Biomol. NMR 36 Suppl. 1 (2006) 33
42. Mantovani F., and Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20 (2001) 7874-7887
43. Ristriani T., Nomine Y., Laurent C., Weiss E., and Trave G. Protein mutagenesis with monodispersity-based quality probing: selective inactivation of p53 degradation and DNA-binding properties of HPV E6 oncoprotein. Protein Expr. Purif. 26 (2002) 357-367
44. Morais Cabral J.H., Petosa C., Sutcliffe M.J., Raza S., Byron O., Poy F., Marfatia S.M., Chishti A.H., and Liddington R.C. Crystal structure of a PDZ domain. Nature 382 (1996) 649-652
45. Karthikeyan S., Leung T., Birrane G., Webster G., and Ladias J.A. Crystal structure of the PDZ1 domain of human Na(+)/H(+) exchanger regulatory factor provides insights into the mechanism of carboxyl-terminal leucine recognition by class I PDZ domains. J. Mol. Biol. 308 (2001) 963-973
46. Piserchio A., Salinas G.D., Li T., Marshall J., Spaller M.R., and Mierke D.F. Targeting specific PDZ domains of PSD-95; structural basis for enhanced affinity and enzymatic stability of a cyclic peptide. Chem. Biol. 11 (2004) 469-473